<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37974068</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>16</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Impact of vaccination and variants of concern on long COVID clinical phenotypes.</ArticleTitle><Pagination><StartPage>804</StartPage><MedlinePgn>804</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">804</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08783-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Defining patterns of symptoms in long COVID is necessary to advance therapies for this heterogeneous condition. Here we aimed to describe clusters of symptoms in individuals with long COVID and explore the impact of the emergence of variants of concern (VOCs) and vaccination on these clusters.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a prospective, multi centre cohort study, individuals with symptoms persisting&#x2009;&gt;&#x2009;4&#xa0;weeks from acute COVID-19 were divided into two groups based on timing of acute infection; pre-Alpha VOC, denoted wild type (WT) group and post-Alpha VOC (incorporating alpha and delta dominant periods) denoted VOC group. We used multiple correspondence analysis (MCA) and hierarchical clustering in the WT and VOC groups to identify symptom clusters. We then used logistic regression to explore factors associated with individual symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 417 individuals were included in the analysis, 268 in WT and 149 in VOC groups respectively. In both groups MCA identified three similar clusters; a musculoskeletal (MSK) cluster characterised by joint pain and myalgia, a cardiorespiratory cluster and a less symptomatic cluster. Differences in characteristic symptoms were only seen in the cardiorespiratory cluster where a decrease in the frequency of palpitations (10% vs 34% p&#x2009;=&#x2009;0.008) and an increase in cough (63% vs 17% p&#x2009;&lt;&#x2009;0.001) in the VOC compared to WT groups was observed. Analysis of the frequency of individual symptoms showed significantly lower frequency of both chest pain (25% vs 39% p&#x2009;=&#x2009;0.004) and palpitations (12% vs 32% p&#x2009;&lt;&#x2009;0.001) in the VOC group compared to the WT group. In adjusted analysis being in the VOC group was significantly associated with a lower odds of both chest pain and palpitations, but vaccination was not associated with these symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggests changes in long COVID phenotype in individuals infected later in the pandemic, with less palpitations and chest pain reported. Adjusted analyses suggest that these effects are mediated through introduction of variants rather than an effect from vaccination.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kenny</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland. grace.kenny1@ucd.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland. grace.kenny1@ucd.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCann</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Conor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Broin</LastName><ForeName>Cathal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tinago</LastName><ForeName>Willard</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousif</LastName><ForeName>Obada</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Wexford General Hospital, Wexford, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Gorman</LastName><ForeName>Tessa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater Misericordiae University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotter</LastName><ForeName>Aoife G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater Misericordiae University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater Misericordiae University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feeney</LastName><ForeName>Eoin R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Barra</LastName><ForeName>Eoghan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Beaumont Hospital, Beaumont, Dublin 9, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of International Health and Tropical Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadlier</LastName><ForeName>Corinna</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cork University Hospital, Wilton, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landay</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doran</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Trials Institute, University of Galway, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savinelli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallon</LastName><ForeName>Patrick W G</ForeName><Initials>PWG</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Belfield Dublin 4, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St Vincent's University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>All Ireland Infectious Diseases Cohort Study</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="N">Chest Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-Acute Sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 variants</Keyword></KeywordList><CoiStatement>E. F. has received consulting fees from Gilead, ViiV, and Vidacare Ireland, and has been awarded a grant from Science Foundation Ireland, outside the submitted work. E. D. B. has received consulting fees from Sanofi Pasteur and honoraria/travel grant from Pfizer. P. W. G. M. has received honoraria and/or travel grants from Gilead Sciences, MSD, Bristol-Myers Squibb, and ViiV Healthcare, and has been awarded grants by Science Foundation Ireland, outside the submitted work. All other authors report no potential conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>MacCann</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia Leon</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miles</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alalwan</LastName><ForeName>Dana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Negi</LastName><ForeName>Riya</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muldoon</LastName><ForeName>Eavan</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheehan</LastName><ForeName>Gerard</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGinty</LastName><ForeName>Tara</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leamy</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kelly</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Barra</LastName><ForeName>Eoin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McConkey</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hurley</LastName><ForeName>Killain</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sulaiman</LastName><ForeName>Imran</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horgan</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eustace</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bracken</LastName><ForeName>Tommy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whelan</LastName><ForeName>Bryan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Low</LastName><ForeName>Justin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>McNicholas</LastName><ForeName>Bairbre</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Courtney</LastName><ForeName>Garry</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gavin</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>15</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37974068</ArticleId><ArticleId IdType="pmc">PMC10655269</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08783-y</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08783-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kenny G, Mallon PW. COVID19- clinical presentation and therapeutic considerations. Biochem Biophys Res Commun. 2021;538:125&#x2013;131. doi: 10.1016/j.bbrc.2020.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.11.021</ArticleId><ArticleId IdType="pmc">PMC7657079</ArticleId><ArticleId IdType="pubmed">33218685</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9:ofac060. doi: 10.1093/ofid/ofac060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas LS, Molteni E, Deng J, et al. Profiling post-COVID syndrome across different variants of SARS-CoV-2. MedRxiv. 2022 doi: 10.1101/2022.07.28.22278159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.28.22278159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, et al. Machine learning for identifying Data-Driven subphenotypes of Incident Post-acute SARS-CoV-2 Infection conditions with Large Scale Electronic Health Records: findings from the RECOVER Initiative. Public Global Health. 2022. 10.1101/2022.05.21.22275412.</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 Infection. Nat Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Twohig KA, Nyberg T, Zaidi A, et al. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect Dis. 2022;22:35&#x2013;42. doi: 10.1016/S1473-3099(21)00475-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00475-8</ArticleId><ArticleId IdType="pmc">PMC8397301</ArticleId><ArticleId IdType="pubmed">34461056</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372:eabg3055. doi: 10.1126/science.abg3055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg3055</ArticleId><ArticleId IdType="pmc">PMC8128288</ArticleId><ArticleId IdType="pubmed">33658326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, Negi R, O&#x2019;Reilly S, et al. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination. J Immunol Methods. 2022;510:113345. doi: 10.1016/j.jim.2022.113345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2022.113345</ArticleId><ArticleId IdType="pmc">PMC9425705</ArticleId><ArticleId IdType="pubmed">36055441</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. COVID-19 Clinical management Living guidance. 2021; published online Jan 25. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1Accessed 23 Sept 2021.</Citation></Reference><Reference><Citation>Stenton C. The MRC breathlessness scale. Occup Med. 2008;58:226&#x2013;227. doi: 10.1093/occmed/kqm162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqm162</ArticleId><ArticleId IdType="pubmed">18441368</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake C, Codd MB, O&#x2019;Meara YM. The short form 36 (SF-36) Health Survey: normative data for the Irish population. Ir J Med Sci. 2000;169:195&#x2013;200. doi: 10.1007/BF03167695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03167695</ArticleId><ArticleId IdType="pubmed">11272876</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Franco G. Multiple correspondence analysis: one only or several techniques? Qual Quant. 2016;50:1299&#x2013;1315. doi: 10.1007/s11135-015-0206-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11135-015-0206-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Protection Surveillance Centre. Summary of COVID-19 virus variants in Ireland Report prepared by HPSC and NVRL on 23/03/2022. http://hdl.handle.net/10147/631713Accessed 9 Aug 2023.</Citation></Reference><Reference><Citation>Althouse AD. Adjust for multiple comparisons? It&#x2019;s not that simple. Ann Thorac Surg. 2016;101:1644&#x2013;1645. doi: 10.1016/j.athoracsur.2015.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.11.024</ArticleId><ArticleId IdType="pubmed">27106412</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S, Tymoszuk P, Ausserhofer D, et al. Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey. Clin Infect Dis. 2022;75(1):e418&#x2013;31.&#xa0;10.1093/cid/ciab978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Thorpe LE, Simon NM, et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: a prospective, observational study. PLoS One. 2022;17:e0275274. doi: 10.1371/journal.pone.0275274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275274</ArticleId><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Florencio LL, et al. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2022 doi: 10.1007/s15010-022-01822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell&#x2019;Isola A, et al. Post-covid medical complaints following Infection with SARS-CoV-2 omicron vs Delta variants. Nat Commun. 2022;13:7363. doi: 10.1038/s41467-022-35240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Plante JA, Liu Y, Liu J, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592:116&#x2013;121. doi: 10.1038/s41586-020-2895-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2895-3</ArticleId><ArticleId IdType="pmc">PMC8158177</ArticleId><ArticleId IdType="pubmed">33106671</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 Illness. Nat Med. 2022;28:2117&#x2013;2123. doi: 10.1038/s41591-022-02000-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02000-0</ArticleId><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Salamun J, et al. Symptoms after COVID-19 vaccination in patients with Post-acute Sequelae of SARS-CoV-2. J Gen Intern Med. 2022;37:1585&#x2013;1588. doi: 10.1007/s11606-022-07443-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07443-2</ArticleId><ArticleId IdType="pmc">PMC8863092</ArticleId><ArticleId IdType="pubmed">35194744</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and Disease profile of post-vaccination SARS-CoV-2 Infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, Blau H, Bergquist T, et al. Generalizable long COVID subtypes: findings from the NIH N3C and RECOVER programs. Infect Dis (except HIV/AIDS) 2022 doi: 10.1101/2022.05.24.22275398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.24.22275398</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>